SSII · SS Innovations International, Inc.
$3.31
+0.01 (+0.30%)
At close · Sep 11
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$669.29M
Shares
200.39M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$3.31
Open$3.30
Day$3.25–3.40
52W close$3.22–9.98
Avg vol 30d45K
Short int73K · 0.0% float · 1.9d
Short vol39%
Last earningsOct 28, 2025
DataAug 2024–Sep 2026
Filing10-Q · Aug 13
Up next
filed Aug 13, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$52.40M
Trailing 12 months
Net income (TTM)
−$12.43M
Trailing 12 months
Revenue growth YoY
+39.4%
Year over year
Operating margin
-15.8%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+3.2%
Year over year · more shares
Price change (1Y)
-48.1%
Trailing year
Short interest
0.0%
Latest settlement · 1.9 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Bearish
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 15.8 · calm
Equity put/call 0.60
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−25%
below
Price vs 50-day avg
−9%
below
RSI (14)
40
neutral
MACD trend
Negative
52-week position
1%
near low
Momentum
relative strength
1-month return
−14%
trailing
6-month return
−33%
trailing
YTD return
−42%
this year
Relative strength
−51%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $4 › 200d $4 — 200d above 50d
Institutional flow
Distributing
-12% holders QoQ · +1 funds added
Insider flow
Distributing
Net -$100.0K over 90 days · 100% sells
Short interest
Rising
0.04% of float · ▲ +7.7% MoM · 1.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
23 holders — mid 1-yr range
Squeeze score
40
elevated · 0–100
Fundamentals
Revenue growth
+106%
Y/Y
Gross margin
46%
expanding
EPS growth
+45%
Y/Y
Free cash flow
$-22.2M
Balance sheet
$1.5M
net cash
Quant / Vol
risk profile
Volatility
92%
annualized · 1-yr
Max drawdown
−68%
past year
ATR
6.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−25%
Bearish
Price vs 50-day avg
−9%
Bearish
RSI (14)
40
Neutral
MACD trend
Negative
Bearish
52-week position
1%
Bearish
Market signals — smart money & positioning
Bearish · 3 of 6
Trend (MA cross)
No cross
50d $4 › 200d $4 — 200d above 50d
Institutional flow
Distributing
-12% holders QoQ · +1 funds added
Insider flow
Distributing
Net -$100.0K over 90 days · 100% sells
Short interest
Rising
0.04% of float · ▲ +7.7% MoM · 1.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
23 holders — mid 1-yr range
Price context
position in its 52-week range
Range low $3
Now $3 · 1%
Range high $10
vs 200-day avg -25%
vs 50-day avg -9%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SSII
this stock
SS Innovations International, Inc.
|
$669.29M | -41.7% | +105.7% | — | 0.0% |
|
ABT
Abbott Laboratories
|
$178.08B | -18.6% | +5.7% | 28.6 | 1.3% |
|
MDT
Medtronic plc
|
$117.19B | -5.3% | +8.4% | 22.6 | 0.9% |
|
SYK
Stryker Corp
|
$103.43B | -21.6% | +11.2% | 27.9 | 2.0% |
|
BSX
Boston Scientific Corp
|
$62.29B | -54.9% | +12.5% | 17.4 | 3.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SSII | -2.4% | -13.6% | -33.0% | -2.9% | -41.7% |
| SPY | -1.2% | -1.8% | +17.8% | -0.4% | +12.1% |
| vs SPY | -1.2% | -11.8% | -50.8% | -2.6% | -53.8% |